Healthcare institutions are currently shifting toward more personalized communication tools to improve patient ...
The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...
News Medical on MSN
FDA label update expands CAR T access for primary CNS lymphoma
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...
Morning Overview on MSN
New FDA-approved device zaps pancreatic cancer with electric fields
The FDA has cleared a wearable device for adults with locally advanced pancreatic cancer that delivers low-intensity electric fields through adhesive patches placed on the skin. In the pivotal ...
Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the ...
athenahealth and b.well Connected Health today announced a new point-of-care workflow allowing patients to securely share their health information digitally during intake—without paper forms, faxes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results